
NIHR NCRF Publications
Read a selection of our most recent peer-reviewed publications over the last two years:
2020/2021
Bellini G., Best L.A., Brechany U., Mills R., Pavese N. Clinical Impact of Deep Brain Stimulation on the Autonomic System in Patients with Parkinson’s Disease. Movement Disorders Clinical Practice. 2020; 7:4 373-382. DOI: 10.1002/mdc3.12938
Campanilho-Marques R., Deakin, C.T., Simou S., Papadopoulou C., Wedderburn L.R., et al. incl. Foster H. Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients. Arthritis Research and Therapy. 2020; 22:1. DOI: 10.1186/s13075-020-02164-5
Colloby SJ, Nathan P, Bakker G, Lawson RA, Yarnall AJ, Burn DJ, O’Brien JT, Taylor JP. Spatial covariance of cholinergic muscarinic M1/M4 receptors in Parkinson’s disease. Accepted, Movement Disorders. 2020.
Del Din S, Kirk C, Yarnall AJ, Rochester L, Hausdorff JM. Body-worn Sensors for Remote Monitoring of Parkinson’s disease Motor Symptoms: Vision, State of the Art, and Challenges Ahead. J Parkinson’s Disease, 2021. DOI 10.3233/JPD-202471.
Hester K.L.M., Ryan V., Newton J., Rapley T., De Soyza A. Bronchiectasis Information and Education: A randomised, controlled feasibility trial. Trials. 2020; 21:1. DOI: 10.1186/s13063-020-4134-5
Hogrel J.-Y., Decostre V., Ledoux I., de Antonio M., Niks E.H., et al. incl. Straub V. Normalized grip strength is a sensitive outcome measure through all stages of Duchenne muscular dystrophy. Journal of Neurology. 2020; 267:7 2022-2028. DOI: 10.1007/s00415-020-09800-9
Kearsley-Fleet L., Heaf E., Davies R., Baildam E., Beresford M.W., Foster H.E., et al. Frequency of biologic switching and the outcomes of switching in children and young people with juvenile idiopathic arthritis: a national cohort study. The Lancet Rheumatology. 2020. DOI: 10.1016/S2665-9913(20)30025-4
Law ZK, Todd C, Mehraram, SChumcher J, Baker M, LeBeau F, Yarnall A, Onofrj M, Bonanni L, Thomas A, Taylor JP (2020). The role of EEG in the diagnosis, prognosis and clinical correlations of dementia with Lewy bodies – a systematic review. Diagnostics, 10:616
Lawson RA, Williams-Gray CH, Camacho M, Duncan GW, Khoo TK, Breen DP, Barker RA, Rochester L, Burn DJ, Yarnall AJ. Which neuropsychological tests? Cognitive decline and predictors of dementia in Parkinson’s disease in the ICICLE-PD cohort. Submitted, Neurology, 14th September 2020.
Lowes H, Robertson F, Pyle A, Hussain R, Coxhead J, Yarnall AJ, Burn D, Payne BAI, Santibanez-Koref M, Hudson G (2020). The human coronavirus receptor ANPEP (CD13) is overexpressed in Parkinson’s disease. Movement Disorders, 35:2134-2136.
McCay K.D., Ho E.S.L., Shum H.P.H., Fehringer G., Marcroft C., Embleton N.D. Abnormal Infant Movements Classification with Deep Learning on Pose-Based Features. IEEE Access. 2020. DOI: 10.1109/ACCESS.2020.2980269
McInnes L., Jones E., Rochester L., Lord S., Chastin S.F.M., Watson A.W., Little L., Briggs P. Mobility in Community Dwelling Older Adults: Predicting Successful Mobility Using an Instrumented Battery of Novel Measures. The Journal of frailty & aging. 2020; 9:2 68-73. DOI: 10.14283/jfa.2019.35
Moore S.A., Hrisos N., Errington L., Rochester L., Rodgers H. Exercise as a treatment for sarcopenia: an umbrella review of systematic review evidence. Physiotherapy (United Kingdom). 2020. DOI: 10.1016/j.physio.2019.08.005
Myat A., Papachristofi O., Trivedi U., Bapat V., Young C., et al. incl. Zaman A. Transcatheter aortic valve implantation via surgical subclavian versus direct aortic access: A United Kingdom analysis. International Journal of Cardiology. 2020; 308 67-72. DOI: 10.1016/j.ijcard.2020.03.059
Naisby J, Amjad, A, Ratcliffe N, Yarnall A, Rochester L, Walker R, Katherine B. A survey of people with Parkinson’s and their carers: The management of pain in Parkinson’s. Submitted, Movement Disorders Clinical Practice, 13th September 2020.
O’brien J., Taylor J.P., Ballard C., Barker R.A., Bradley C., et al. Visual hallucinations in neurological and ophthalmological disease: Pathophysiology and management. Journal of Neurology, Neurosurgery and Psychiatry. 2020; 91:5 512-519. DOI: 10.1136/jnnp-2019-322702
Ramsay N, Macleod AD, Alves G, Camacho M, Forsgren L, Lawson RA, Maple-Grødem J, Tysnes OB, Williams-Gray CH, Yarnall AJ, Counsell CE (2020). Validating a UPDRS-/MDS-UPDRS-based definition of functional dependency for Parkinson’s disease. Parkinsonism and Related Disorders; 76: 49-53
Razvi S., Leng O., Jabbar A., Bano A., Ingoe L., et al. incl. Zaman A. Sample Timing, Diagnosis of Subclinical Thyroid Dysfunction and Mortality in Acute Myocardial Infarction: ThyrAMI1 Study. The Journal of clinical endocrinology and metabolism. 2020. DOI: 10.1210/clinem/dgz143
Rodrigues A.M., Haste A., Penn L., Bell R., Summerbell C., et al. Stakeholders’ perceptions and experiences of the National Health Service diabetes prevention programme in England: Qualitative study with service users, intervention providers and deliverers, commissioners and referrers. BMC Health Services Research. 2020; 20:1. DOI: 10.1186/s12913-020-05160-2
Russell O.M., Gorman G.S., Lightowlers R.N., Turnbull D.M. Mitochondrial Diseases: Hope for the Future. Cell. 2020. 10.1016/j.cell.2020.02.051
Shea C., Witham M.D. Association between the Use of Angiotensin-Blocking Medications with Hip Fracture and Death in Older People. The Journal of frailty & aging. 2020; 9:2 107-110. DOI: 10.14283/jfa.2019.38
Shoop-Worrall S.J.W., Hyrich K.L., Verstappen S.M.M., Sergeant J.C., Baildam E., et al. incl. Foster H. Comparing Proxy, Adolescent, and Adult Assessments of Functional Ability in Adolescents With Juvenile Idiopathic Arthritis. Arthritis Care and Research. 2020. DOI: 10.1002/acr.23877
Tahir W., Monahan M., Dorling J., Hewer O., Bowler U., et al. incl. Embleton N. Economic evaluation alongside the Speed of Increasing milk Feeds Trial (SIFT). Archives of Disease in Childhood: Fetal and Neonatal Edition. 2020; 105:6 587-592. DOI: 10.1136/archdischild-2019-318346
Waite S, Maitland S, Thomas A, Yarnall AJ (2020). Sarcopenia and frailty in individuals with dementia: a systematic review. Archives of Gerontology and Geriatrics, 92:104268.
Warmerdam E., Hausdorff J.M., Atrsaei A., Zhou Y., Mirelman A., et al. incl. Rochester L. Long-term unsupervised mobility assessment in movement disorders. The Lancet Neurology. 2020; 19:5 462-470. DOI: 10.1016/S1474-4422(19)30397-7
Wilson J, Yarnall AJ, Craig CE, Galna B, Lord S, Morris R, Lawson RA, Alcock L, Duncan GW, Khoo TK, O’Brien JT, Burn DJ, Taylor JP, Ray NJ, Rochester L (2021). Cholinergic basal forebrain volumes predict gait decline in early Parkinson’s disease. Movement Disorders, DOI: 10.1002/mds.28453.
Wilson J, Alcock L, Yarnall AJ, Lord S, Lawson RA, Morris R, Taylor JP, Burn DJ, Rochester L, Galna B (2020). Gait progression over six years in Parkinson’s disease: Effects of age, medication and pathology. Frontiers in Aging Neuroscience, 12: 577435.
Witham M.D., Band M., Ahmed A., Almond M.K., Balasubramaniam G., et al. Clinical and cost-effectiveness of oral sodium bicarbonate therapy for older patients with chronic kidney disease and low-grade acidosis (BiCARB): A pragmatic randomised, double-blind, placebo-controlled trial. BMC Medicine. 2020; 18:1. DOI: 10.1186/s12916-020-01542-9
Yarnall AJ, Granic A, Waite S, Hollingsworth KG, Warren C, Vincent AE, Turnbull DM, Taylor RW, Dodds RM, Sayer AA (2020). The feasibility of muscle mitochondrial respiratory chain phenotyping across the cognitive spectrum in Parkinson’s disease. Experimental Gerontology, 138: 110997.
Yiu Z.Z.N., Mason K.J., Hampton P.J., Reynolds N.J., Smith C.H., et al. Drug survival of adalimumab, ustekinumab and secukinumab in patients with psoriasis: a prospective cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR). British Journal of Dermatology. 2020; 183:2 294-302. DOI: 10.1111/bjd.18981
Colloby SJ, Nathan P, Bakker G, Lawson RA, Yarnall AJ, Burn DJ, O’Brien JT, Taylor JP. Spatial covariance of cholinergic muscarinic M1/M4 receptors in Parkinson’s disease. Accepted, Movement Disorders, 1st March 2021.
2019/20
Aitken S., Firth H.V., McRae J., Halachev M., Kini U., et al. incl. Burn J. Finding Diagnostically Useful Patterns in Quantitative Phenotypic Data. American Journal of Human Genetics. 2019. DOI: 10.1016/j.ajhg.2019.09.015.
Al-Banaa I., Hawkins L., Hill S.L., Lupton D.J., Jackson G., et al. incl. Thomas S.H.L. Effect of the UK Psychoactive Substances Act 2016 on episodes of toxicity related to new psychoactive substances as reported to the National Poisons Information Service. A time series analysis. International Journal of Drug Policy. 2020. DOI: 10.1016/j.drugpo.2020.102672
Al-bayati A., Brown A., Walker M. Impaired enhancement of insulin action in cultured skeletal muscle cells from insulin resistant type 2 diabetic patients in response to contraction using electrical pulse stimulation. Journal of Diabetes and its Complications. 2019. DOI: 10.1016/j.jdiacomp.2019.107412
Al-Laith M., Jasenecova M., Abraham S. et al inc. Pratt A.G. and Isaacs J.D. Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): A multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol. Trials. 20:1. 2019. DOI: 10.1186/s13063-019-3403-7
Allan L.M., Wheatley A., Smith A., Flynn E., Homer T., et al. incl. Barber R. An intervention to improve outcomes of falls in dementia: The DIFRID mixed-methods feasibility study. Health Technology Assessment. 2019. DOI: 10.3310/hta23590
Alston C.L., Veling M.T., Heidler J., Taylor L.S., Alaimo J.T., et al. incl. McFarland R. Pathogenic Bi-allelic Mutations in NDUFAF8 Cause Leigh Syndrome with an Isolated Complex I Deficiency. American Journal of Human Genetics. 2020. DOI: 10.1016/j.ajhg.2019.12.001
Alwan F., Vendramin C., Liesner R., Clark A., Lester W., et al. incl. Biss T. Characterization and treatment of congenital thrombotic thrombocytopenic purpura. Blood. 2019. 133.15 DOI: 10.1182/blood-2018-11-884700
Ambrosini A., Quinlivan R., Sansone V.A., Meijer I. et al inc. Lochmüller H. Be an ambassador for change that you would like to see: A call to action to all stakeholders for co-creation in healthcare and medical research to improve quality of life of people with a neuromuscular disease. Orphanet Journal of Rare Diseases. 14:1. 2019. DOI: 10.1186/s13023-019-1103-8
an M.M.X., Malek N., Lawton M.A., Hubbard L., et al incl. Burn D.J., Genetic analysis of Mendelian mutations in a large UK population-based Parkinson’s disease study. Brain : a journal of neurology. 2019. 142:0 2828-2844. DOI: 10.1093/brain/awz191
Anderson A.E., Maney N.J., Nair N., et al inc. Isaacs J.D. and Pratt A.G. Expression of STAT3-regulated genes in circulating CD4+ T cells discriminates rheumatoid arthritis independently of clinical parameters in early arthritis. Rheumatology (United Kingdom). 58:7. 1250-1258. 2019. DOI: 10.1093/rheumatology/kez003
Andreazza S., Samstag C.L., Sanchez-Martinez A., Fernandez-Vizarra E. et al inc. Chinnery P.F. Mitochondrially-targeted APOBEC1 is a potent mtDNA mutator affecting mitochondrial function and organismal fitness in Drosophila. Nature Communications. 10:1 2019. DOI: 10.1038/s41467-019-10857-y
Anstee Q.M., Lawitz E.J., Alkhouri N., Wong V.W.-S., Romero-Gomez M., et al. Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials. Hepatology. 2019. DOI: 10.1002/hep.30842
Arefi M., Wilson V., Muthiah S., Zwolinski S., Bajwa D., et al. incl. Burn J. Diverse presentations of cutaneous mosaicism occur in CYLD cutaneous syndrome and may result in parent-to-child transmission. Journal of the American Academy of Dermatology. 2019. DOI: 10.1016/j.jaad.2019.05.021.
Ashburn A., Pickering R., McIntosh E., Hulbert S., et al inc. Rochester L. Exercise- and strategy-based physiotherapy-delivered intervention for preventing repeat falls in people with Parkinson’s: the PDSAFE RCT. Health technology assessment (Winchester, England). 23:36. 1-150. 2019. DOI: 10.3310/hta23360
Baker K.F., Skelton A.J., Lendrem D.W., et al Inc., Pratt A.G. and Isaacs J.D. Predicting drug-free remission in rheumatoid arthritis: A prospective interventional cohort study. Journal of Autoimmunity. 2019. DOI: 10.1016/j.jaut.2019.06.009
Bano A., Gan E., Addison C., Narayanan K., Weaver J.U., Tsatlidis V., Razvi S. Age May Influence the Impact of TRAbs on Thyroid Function and Relapse-Risk in Patients With Graves Disease. The Journal of clinical endocrinology and metabolism. 2019; 104:5 1378-1385 DOI: 10.1210/jc.2018-01738
Bennett J.L., Wood A., Smith N., Mistry R., Allen K., et al. incl. Foster H.E. Can quantitative MRI be used in the clinical setting to quantify the impact of intra-articular glucocorticoid injection on synovial disease activity in juvenile idiopathic arthritis? Pediatric Rheumatology. 2019. DOI: 10.1186/s12969-019-0377-7
Bernier M.-O., Baysson H., Moissonnier M., Cardis E., et al inc. Pearce M.S. Cohort profile: The EPI-CT study: A European pooled epidemiological study to quantify the risk of radiation-induced cancer from paediatric CT. International Journal of Epidemiology. 48:2. 379-381. 2019. DOI: 10.1093/ije/dyy231
Beska B., Chan D., Gu S., et al incl. Kunadian V. and Neely D. The association between Vitamin D status and clinical events in high-risk older patients with non-ST elevation acute coronary syndrome undergoing invasive management. PLoS ONE. 14:6. 2019. DOI: 10.1371/journal.pone.0217476
Blackstock S., Witham M.D., Wade A.N., Crampin A., Beran D. Ability of verbal autopsy data to detect deaths due to uncontrolled hyperglycaemia: Testing existing methods and development and validation of a novel weighted score. BMJ Open. 2019. DOI: 10.1136/bmjopen-2018-026331
Blakeway H., Van-de-Velde V., Allen V.B., Kravvas G., et al. incl. Reynolds N. What is the evidence for interactions between filaggrin null mutations and environmental exposures in the aetiology of atopic dermatitis? A systematic review. British Journal of Dermatology. 2019. DOI: 10.1111/bjd.18778
Boal R.L., Ng Y.S., Pickett S.J., Schaefer A.M., et al incl. McFarland R. and Gorman G. Height as a Clinical Biomarker of Disease Burden in Adult Mitochondrial Disease. The Journal of clinical endocrinology and metabolism. 2019; 104:6 2057-2066. DOI: 10.1210/jc.2018-00957
Bonnemaijer P.W.M., Leeuwen E.M., Iglesias A.I., Gharahkhani P., et al. incl. Steel D. Multi-trait genome-wide association study identifies new loci associated with optic disc parameters. Communications Biology. 2019. DOI: 10.1038/s42003-019-0634-9
Bradley J.M., Anand R., O’Neill B., Ferguson K., Clarke M., et al. incl. De Soyza A. A 2 × 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults with bronchiectasis: A protocol for the CLEAR clinical trial. Trials. 2019. DOI: 10.1186/s13063-019-3766-9
Bronsky J., Campoy C., Fewtrell M., Mis N.F., et al. inc. Embleton N., Palm Oil and Beta-palmitate in Infant Formula: A Position Paper by the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Committee on Nutrition, Journal of pediatric gastroenterology and nutrition, May 2019. 68:5. DOI: 10.1097/MPG.0000000000002307
Buckley C., Micó-Amigo M.E., Dunne-Willows M., Godfrey A., Hickey A., et al. incl. Rochester L. Gait asymmetry post-stroke: Determining valid and reliable methods using a single accelerometer located on the trunk. Sensors (Switzerland). 2020. DOI: 10.3390/s20010037
Burn J. Molecular diagnostics in the screening, detection and diagnosis of cancer. European Oncology and Haematology. 2019. DOI: 10.17925/eoh.2019.15.2.84
Campbell P., Lewis M., Chen Y., Lacey R.J. et al inc. Rowlands G. Can patients with low health literacy be identified from routine primary care health records? A cross-sectional and prospective analysis. BMC family practice. 20:1 2019. DOI: 10.1186/s12875-019-0994-8
Cassidy S., Okwose N., Scragg J., Houghton D., Ashley K., et al. incl. Hallsworth K and Jakovljevic D.G. Assessing the feasibility and acceptability of Changing Health for the management of prediabetes: Protocol for a pilot study of a digital behavioural intervention. Pilot and Feasibility Studies. 2019. DOI: 10.1186/s40814-019-0519-1
Cassidy S., Okwose N., Scragg J., Houghton D., Ashley K., Trenell M.I. Assessing the feasibility and acceptability of Changing Health for the management of prediabetes: Protocol for a pilot study of a digital behavioural intervention. Pilot and Feasibility Studies. 2019. DOI: 10.1186/s40814-019-0519-1
Cegla J., Neely R.D.G., France M., Ferns G., Byrne C.D., Halcox J. HEART UK consensus statement on Lipoprotein(a): A call to action. Atherosclerosis. 2019. DOI: 10.1016/j.atherosclerosis.2019.10.011
Chan D., Martin-Ruiz C., Saretzki G., Neely D., Qiu W., Kunadian V. The association of telomere length and telomerase activity with adverse outcomes in older patients with non-ST-elevation acute coronary syndrome. PLoS ONE. 2020. DOI: 10.1371/journal.pone.0227616
Chapman M.H., Thorburn D., Hirschfield G.M., Webster G.G.J., et al inc. Dyson J. British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis. Gut. 2019. DOI: 10.1136/gutjnl-2018-317993
Chappell L.C., Brocklehurst P., Green M.E., Hunter R., Hardy P., et al. incl. Robson S. Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial. The Lancet. 2019. DOI: 10.1016/S0140-6736(19)31963-4
Charman S., Okwose N., Maniatopoulos G., Graziadio S., Metzler T. et al. incl. Jakovljevic D.G. Opportunities and challenges of a novel cardiac output response to stress (CORS) test to enhance diagnosis of heart failure in primary care: Qualitative study. BMJ Open. 2019; 9:4 e028122 DOI: 10.1136/bmjopen-2018-028122
Chen Y.-L., Gomes T., Hardman C.S., Vieira Braga F.A., Gutowska-Owsiak D., et al. incl. Reynolds G. Re-evaluation of human BDCA-2+ DC during acute sterile skin inflammation. The Journal of experimental medicine. 2020. DOI: 10.1084/jem.20190811
Chua S.Y.L., Dhillon B., Aslam T., Balaskas K., Yang Q., et al incl. Steel M.D. Associations with photoreceptor thickness measures in the UK Biobank. Scientific Reports. 2019. DOI: 10.1038/s41598-019-55484-1
Ciafone J., Little B., Thomas A.J., Gallagher P. The Neuropsychological Profile of Mild Cognitive Impairment in Lewy Body Dementias. Journal of the International Neuropsychological Society. 2019. DOI: 10.1017/S1355617719001103
Clark A.D., Nair N., Anderson A.E., Thalayasingam N., Naamane N., et al. incl. Pratt A.G. Lymphocyte DNA methylation mediates genetic risk at shared immune-mediated disease loci. Journal of Allergy and Clinical Immunology. 2020. DOI: 10.1016/j.jaci.2019.12.910
Clifford T., Babateen A., Shannon O.M., et al inc. Mathers J.C., Siervo. M. Effects of inorganic nitrate and nitrite consumption on cognitive function and cerebral blood flow: A systematic review and meta-analysis of randomized clinical trials. Critical Reviews in Food Science and Nutrition. 59:15 2400-2410. 2019. DOI: 10.1080/10408398.2018.1453779
Colver A., Rapley T., Parr J.R., McConachie H., Dovey-Pearce G. Facilitating transition of young people with long-term health conditions from children’s to adults’ healthcare services – implications of a 5-year research programme. Clinical medicine (London, England). 2020. DOI: 10.7861/clinmed.2019-0077
Conrado D.J., Larkindale J., Berg A., Hill M., et al. incl. Guglieri M. Towards regulatory endorsement of drug development tools to promote the application of model-informed drug development in Duchenne muscular dystrophy. Journal of Pharmacokinetics and Pharmacodynamics. 2019. DOI: 10.1007/s10928-019-09642-7
Cro S., Patel P., Barker J., Burden D.A., Griffiths C.E.M., et al. incl. Reynolds N.J. A randomised placebo controlled trial of anakinra for treating pustular psoriasis: Statistical analysis plan for stage two of the APRICOT trial. Trials. 2020. DOI: 10.1186/s13063-020-4103-z
Crosbie E.J., Ryan N.A.J., Arends M.J., Bosse T., Burn J. Manchester International Consensus Group
The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome. Genetics in Medicine. 2019. DOI: 10.1038/s41436-019-0489-y.
Cunningham P.S., Meijer P., Nazgiewicz A., Anderson S.G., Borthwick L.A., et al. incl. Fisher A.J. The circadian clock protein REVERBα inhibits pulmonary fibrosis development. Proceedings of the National Academy of Sciences of the United States of America. 2020. DOI: 10.1073/pnas.1912109117
Cunningham P.S., Meijer P., Nazgiewicz A., Anderson S.G., Borthwick L.A. The circadian clock protein REVERBα inhibits pulmonary fibrosis development. Proceedings of the National Academy of Sciences of the United States of America. 2020. DOI: 10.1073/pnas.1912109117
Davies K., Mirza K., Tarn J., Howard-Tripp N.et al. incl. Ng W.-F. Fatigue in primary Sjögren’s syndrome (pSS) is associated with lower levels of proinflammatory cytokines: a validation study. Rheumatology International. 2019. DOI: 10.1007/s00296-019-04354-0
De Vries M.C., Brown D.A., Allen M.E., Bindoff L., Gorman G.S., et al. incl. McFarland R. Safety of drug use in patients with a primary mitochondrial disease: An international Delphi-based consensus. Journal of Inherited Metabolic Disease. 2020. DOI: 10.1002/jimd.12196
Del Din S., Elshehabi M., Galna B., Hobert M.A., et al inc. Rochester L., Gait analysis with wearables predicts conversion to parkinson disease. Annals of Neurology. 86:3. 357-367. 2019. DOI: 10.1002/ana.25548
Del Din S., Yarnall A.J., Barber T.R., Lo C., Crabbe M., et al. incl. Rochester L. Continuous Real-World Gait Monitoring in Idiopathic REM Sleep Behavior Disorder. Journal of Parkinson’s Disease. 2020. DOI: 10.3233/JPD-191773
Dismore L.L., Echevarria C., Van Wersch A., Gibson J., Bourke S. What are the positive drivers and potential barriers to implementation of hospital at home selected by low-risk DECAF score in the UK: A qualitative study embedded within a randomised controlled trial. BMJ Open. 2019; 9:4 e026609 DOI: 10.1136/bmjopen-2018-026609
Dlay J.K., Duncan G.W., Khoo T.K., Williams-Gray C.H., et al. incl. Burn D.J. and Yarnall A.J. Progression of neuropsychiatric symptoms over time in an incident parkinson’s disease cohort (ICICLE-PD). Brain Sciences. 2020. DOI: 10.3390/brainsci10020078
Dominguez-Valentin M., Seppälä T.T., Sampson J.R., MacRae F., Winship I., et al. incl. Burn J. Survival by colon cancer stage and screening interval in Lynch syndrome: A prospective Lynch syndrome database report. Hereditary Cancer in Clinical Practice. 2019. DOI: 10.1186/s13053-019-0127-3.
Dominguez-Valentin M., Sampson J.R., Seppälä T.T., ten Broeke S.W., Plazzer J.-P., et al inc. Burn J. Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database. Genetics in Medicine. 2019. DOI: 10.1038/s41436-019-0596-9
Dorling J., Abbott J., Berrington J., Bosiak B., Bowler U., et al. incl. Embleton N. Controlled trial of two incremental milk-feeding rates in preterm infants. New England Journal of Medicine. 2019. DOI: 10.1056/NEJMoa1816654
Durcan R., Donaghy P.C., Barnett N.A., Olsen K., Yarnall A.J. et al. incl. Taylor J.-P. Prevalence and severity of symptoms suggestive of gastroparesis in prodromal dementia with Lewy bodies. International Journal of Geriatric Psychiatry. 2019. DOI: 10.1002/gps.5100
Ellis R., Tang D., Nasr B., Greenwood A.,et al inc. Reynolds N.J. Epidermal autophagy and beclin 1 regulator 1 and loricrin: a paradigm shift in the prognostication and stratification of the American Joint Committee on Cancer stage I melanomas. British Journal of Dermatology. 2019. DOI: 10.1111/bjd.18086
Ellis R., Tang D., Nasr B., Greenwood A., McConnell A., et al. incl. Reynolds N.J. Epidermal autophagy and beclin 1 regulator 1 and loricrin: a paradigm shift in the prognostication and stratification of the American Joint Committee on Cancer stage I melanomas. British Journal of Dermatology. 2020. DOI: 10.1111/bjd.18086
Embleton N.D., McGuire W., Commentary on “higher versus Lower Amino Acid Intake in Parenteral Nutrition for Newborn Infants” Neonatology. 92:96. 2019. DOI: 10.1159/000495913
Erskine D., Taylor J.-P., Bakker G., Brown A.J.H., Tasker T. Cholinergic muscarinic M1 and M4 receptors as therapeutic targets for cognitive, behavioural, and psychological symptoms in psychiatric and neurological disorders. Drug Discovery Today. 2019. DOI: 10.1016/j.drudis.2019.08.009
Farina N., Hicks B., Baxter K., Birks Y., Brayne C., et al. incl. Thomas A. DETERMinants of quality of life, care and costs, and consequences of INequalities in people with Dementia and their carers (DETERMIND): A protocol paper. International Journal of Geriatric Psychiatry. 2019. DOI: 10.1002/gps.5246
Feeney C.L., Lim A.Z., Fagan E., Blain A., Bright A., et al. incl. McFarland R and Turnbull D.M. A case-comparison study of pregnant women with mitochondrial disease – what to expect? BJOG: An International Journal of Obstetrics and Gynaecology. 2019. DOI: 10.1111/1471-0528.15667
Fellermann H., Shirt-Ediss B., Kozyra J., Linsley M., et al inc. Isaacs J. Design of experiments and the virtual PCR simulator: An online game for pharmaceutical scientists and biotechnologists. Pharmaceutical Statistics. 18:4 402-406. 2019. DOI: 10.1002/pst.1932
Ferreras L., Moles A., Situmorang G.R., el Masri R., Wilson I.L. et al. incl. Sheerin N.S. Heparan sulfate in chronic kidney diseases: Exploring the role of 3-O-sulfation. Biochimica et Biophysica Acta – General Subjects. 2019; 1863: 5 839-848 DOI: 10.1016/j.bbagen.2019.02.009
Flatt A.J.S., Bennett D., Counter C., Brown A.L., White S.A., Shaw J.A.M. β-Cell and renal transplantation options for diabetes. Diabetic Medicine. 2019. DOI: 10.1111/dme.14177
Flatt A.J.S., Little S.A., Speight J., Leelarathna L., Walkinshaw E. Predictors of Recurrent Severe Hypoglycemia in Adults With Type 1 Diabetes and Impaired Awareness of Hypoglycemia During the HypoCOMPaSS Study. Diabetes care. 2020. DOI: 10.2337/dc19-0630
Flatt A.J.S., Little S.A., Speight J., Leelarathna L., Walkinshaw E., et al. incl. Shaw J.A.M. Predictors of recurrent severe hypoglycemia in adults with type 1 diabetes and impaired awareness of hypoglycemia during the hypocompass study. Diabetes Care. 2020. DOI: 10.2337/dc19-0630
Frith J., Newton J.L. Author response: The efficacy of nonpharmacologic intervention for orthostatic hypotension associated with aging. Neurology. 2019; 92:14 683 DOI: 10.1212/WNL.0000000000007228
Frith J., Newton J.L. Combination non-pharmacologic intervention for orthostatic hypotension in older people: a phase 2 study. Age and ageing. 2020. DOI: 10.1093/ageing/afz173
Gardner L.C.S., Grantham H.J., Reynolds N.J., IL-17 May Be a Key Cytokine Linking Psoriasis and Hyperglycemia. Journal of Investigative Dermatology. 2019. 139:6. DOI: 10.1016/j.jid.2019.02.038
Glover E.K., Jordan N., Sheerin N.S., Ali S. Regulation of Endothelial-to-Mesenchymal Transition by MicroRNAs in Chronic Allograft Dysfunction. Transplantation. 2019; 103:4 e64-e73 DOI: 10.1097/TP.0000000000002589
Goode E.C., Clark A.B., Mells G.F., Srivastava B., Spiess K. et al. incl. Hudson M. UK-PSC Consortium. Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System. Hepatology. 2019; 69:5 2120-2135 DOI: 10.1002/hep.30479
Gorman K.M., Meyer E., Spinelli E., et al incl. Talks K, Straub V, Chinnery P. Bi-allelic Loss-of-Function CACNA1B Mutations in Progressive Epilepsy-Dyskinesia. American Journal of Human Genetics. 2019; 104:5. 948-956. DOI: 10.1016/j.ajhg.2019.03.005
Granic A., Hurst C., Dismore L., Davies K., et al. inc. Aspray T and Sayer, A.A. Milk and resistance exercise intervention to improve muscle function in community-dwelling older adults at risk of sarcopenia (MIlkMAN): Protocol for a pilot study. BMJ Open. 2019. DOI: 10.1136/bmjopen-2019-031048
Granic A., Mendonça N., Sayer A.A., Hill T.R., Davies K., et al. incl. Mathers J.C. Effects of dietary patterns and low protein intake on sarcopenia risk in the very old: The Newcastle 85+ study. Clinical Nutrition. 2020. DOI: 10.1016/j.clnu.2019.01.009
Griffiths P.D., Bradburn M., Campbell M.J., Cooper C.L., Embleton N. MERIDIAN Collaborative Group. MRI in the diagnosis of fetal developmental brain abnormalities: The MERIDIAN diagnostic accuracy study. Health Technology Assessment. 2019. 10.3310/hta23490
Hackett K.L., Davies K., Tarn J., Bragg R., Hargreaves B., et al. incl. Ng W.-F. Pain and depression are associated with both physical and mental fatigue independently of comorbidities and medications in primary Sjögren’s syndrome. RMD Open. 2019. 5:1 DOI: 10.1136/rmdopen-2018-000885
Hanna M.G., Badrising U.A., Benveniste O., Lloyd T.E., et al inc. Miller J.A.L. Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial. The Lancet. Neurology. 18:9. 834-844. 2019. DOI: 10.1016/S1474-4422(19)30200-5
Harbron R.W., Ainsbury E.A., Barnard S.G.R., Lee C., et al inc. Pearce M.S. Radiation dose to the lens from CT of the head in young people. Clinical Radiology. 2019. DOI: 10.1016/j.crad.2019.06.029
Harbron R.W., Ainsbury E.A., Barnard S.G.R., Lee C., McHugh K., et al. incl. Pearce M.S. Radiation dose to the lens from CT of the head in young people. Clinical Radiology. 2019. DOI: 10.1016/j.crad.2019.06.029
Haworth S., Shapland C.Y., Hayward C., Prins B.P., Felix J.F., et al. incl. Parr J.R. Low-frequency variation in TP53 has large effects on head circumference and intracranial volume. Nature Communications. 2019. DOI: 10.1038/s41467-018-07863-x
Hellyer T.P., McAuley D.F., Walsh T.S., Anderson N., Conway Morris A., et al. incl. Baudouin S.V. Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluation. The Lancet Respiratory Medicine. 2020. DOI: 10.1016/S2213-2600(19)30367-4
Hodgson J., Swietlik E.M., Salmon R.M., Hadinnapola C., Nikolic I., et al. incl. Corris P.A. Characterization of GDF2 mutations and levels of BMP9 and BMP10 in pulmonary arterial hypertension. American Journal of Respiratory and Critical Care Medicine. 2020. DOI: 10.1164/rccm.201906-1141OC
Holliday R.S., Campbell J., Preshaw P.M. Effect of nicotine on human gingival, periodontal ligament and oral epithelial cells. A systematic review of the literature. Journal of Dentistry. 2019. DOI: 10.1016/j.jdent.2019.05.030
Hussain A.B., Samuel R., Hegade V.S., Jones D.E., Reynolds N.J. Pruritus secondary to primary biliary cholangitis: a review of the pathophysiology and management with phototherapy. British Journal of Dermatology. 2019. DOI: 10.1111/bjd.17933
Hussain A.B., Samuel R., Hegade V.S., Jones D.E., Reynolds N.J. Pruritus secondary to primary biliary cholangitis: a review of the pathophysiology and management with phototherapy. British Journal of Dermatology. 2019. DOI: 10.1111/bjd.17933
Ibanez-Bruron M.C., Solebo A.L., Cumberland P.M., Rahi J.S., et al incl. Steel D. Vulnerabilities in diabetic eye screening for children and young people in England. Pediatric Diabetes. 2019. DOI: 10.1111/pedi.12887
Jabbari E., Holland N., Chelban V., Jones P.S., Lamb R., et al. incl. Burn D.J. and Pavese N. Diagnosis across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome. JAMA Neurology. 2019. DOI: 10.1001/jamaneurol.2019.4347
Jardine L., Wiscombe S., Reynolds G., McDonald D., Fuller A., et al. incl. Simpson A.J. and Forrest, I. Lipopolysaccharide inhalation recruits monocytes and dendritic cell subsets to the alveolar airspace. Nature Communications. 2019. DOI: 10.1038/s41467-019-09913-4
Joharatnam-Hogan N., Cafferty F., Hubner R., Swinson D., Sothi S., et al. incl. Burn J. Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial. The Lancet Gastroenterology and Hepatology. 2019. DOI: 10.1016/S2468-1253(19)30289-4.
Jurkute N., Leu C., Pogoda H.-M., Arno G. et al inc. Yu-Wai-Man P., SSBP1 mutations in dominant optic atrophy with variable retinal degeneration. Annals of Neurology. 86:3. 368-383. 2019. DOI: 10.1002/ana.25550
Kampouraki E., Wynne H., Avery P., Kamali F. Validation of an algorithm to predict decline in INR following warfarin cessation in patients undergoing invasive procedures. Journal of Thrombosis and Thrombolysis. 2019. DOI: 10.1007/s11239-019-02017-2
Khanna A., Jopson L., Howel D., Bryant A., et al. incl. Newton J.L. and Jones D.E. Rituximab Is Ineffective for Treatment of Fatigue in Primary Biliary Cholangitis: A Phase 2 Randomized Controlled Trial. Hepatology. 2019. DOI: 10.1002/hep.30099
King E., O’Brien J., et al. inc. Taylor J-P, Burn, D.J, Yarnall A.J., Inflammation in mild cognitive impairment due to Parkinson’s disease, Lewy body disease, and Alzheimer’s disease. International Journal of Geriatric Psychiatry. 2019. DOI: 10.1002/gps.5124
Kitas G.D., Nightingale P., Armitage J., Sattar N., Belch J.J.F., et al. incl. Birrell F. A Multicenter, Randomized, Placebo-Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis. Arthritis and Rheumatology. 2019. DOI: 10.1002/art.40892
Klopstock T., Tricta F., Neumayr L., et al. incl. Horvath R and Chinnery P. Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study. The Lancet Neurology. 18:7. 631-642. 2019. DOI: 10.1016/S1474-4422(19)30142-5
Kunadian V., Wilson N., Stocken D.D., Ali H., McColl E., et al. incl. Fisher, A. Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: A randomised controlled proof-of-concept trial. ERS Monograph. 2019. DOI: 10.1183/23120541.00110-2019
Ladak S.S., Roebuck E., Powell J., Fisher A.J., Ward C. The Role of miR-200b-3p in Modulating TGF-β1-induced Injury in Human Bronchial Epithelial Cells. Transplantation. 2019. DOI: 10.1097/TP.0000000000002845
Landfeldt E., Nikolenko N., Jimenez-Moreno C., Cumming S., Monckton D.G., et al. incl. Gorman, G and Lochmüller H. Activities of daily living in myotonic dystrophy type 1. Acta Neurologica Scandinavica. 2019. DOI: 10.1111/ane.13215
Lawson R.A., Richardson S.J., Yarnall A.J., Burn D.J., Allan L.M. Identifying delirium in Parkinson disease: A pilot study. International Journal of Geriatric Psychiatry. 2020. DOI: 10.1002/gps.5270
Leitch A.C., Abdelghany T.M., Probert P.M., Dunn M.P., Meyer S.K., et al. incl. Jones D.E. The toxicity of the methylimidazolium ionic liquids, with a focus on M8OI and hepatic effects. Food and Chemical Toxicology. 2020. DOI: 10.1016/j.fct.2019.111069
Lendrem B.C., Lendrem D.W.,Ng W.-F. et al inc. Isaacs J.D., Pratt A.G. Between a ROC and a hard place: Teaching prevalence plots to understand real world biomarker performance in the clinic. Pharmaceutical Statistics. 2019. DOI: 10.1002/pst.1963
Lendrem B.C., Lendrem D.W., Pratt A.G., Naamane N., McMeekin P. Between a ROC and a hard place: Teaching prevalence plots to understand real world biomarker performance in the clinic. Pharmaceutical Statistics. 2019. DOI: 10.1002/pst.1963
Ling H., Gelpi E., Davey K., Jaunmuktane Z., Mok K.Y., et al. incl. Attems J. Fulminant corticobasal degeneration: a distinct variant with predominant neuronal tau aggregates. Acta Neuropathologica. 2020. DOI: 10.1007/s00401-019-02119-4
Lois N., Cook J., Aldington S., Waugh N., et al inc. Steel D., Effectiveness of Multimodal imaging for the Evaluation of Retinal oedema and new vesseLs in Diabetic retinopathy (EMERALD). BMJ Open. 2019. 9:6. DOI: 10.1136/bmjopen-2018-027795
MacGowan G.A., Dark J.H., Corris P.A., Nair A.R. Effects of drug abuse, smoking and alcohol on donor hearts and lungs. Transplant International. 2019. DOI: 10.1111/tri.13468
MacGowan G.A., Dark J.H., Corris P.A., Nair A.R. Effects of drug abuse, smoking and alcohol on donor hearts and lungs. Transplant International. 2019. DOI: 10.1111/tri.13468
Malek N., Kanavou S., Lawton M.A., Pitz V, et al. incl. Burn D.J. L-dopa responsiveness in early Parkinson’s disease is associated with the rate of motor progression. Parkinsonism and Related Disorders, 2019, DOI: 10.1016/j.parkreldis.2019.05.022
Martin J.M., Moledina S., Newnham M., Peacock A.J., et al inc.., Corris P. Traffic exposures, air pollution and outcomes in pulmonary arterial hypertension: a UK cohort study analysis. The European respiratory journal. 53:5. 2019. DOI: 10.1183/13993003.01429-2018
Martin-Ruiz C., Williams-Gray C.H., Yarnall A.J., Boucher J.J., Lawson R.A. Senescence and Inflammatory Markers for Predicting Clinical Progression in Parkinson’s Disease: The ICICLE-PD Study. Journal of Parkinson’s Disease. 2020. DOI: 10.3233/JPD-191724
Martínez-Burgo B., Cobb S.L., Pohl E., Kashanin D. et al. inc. Sheerin N.S., A C-terminal CXCL8 peptide based on chemokine–glycosaminoglycan interactions reduces neutrophil adhesion and migration during inflammation. Immunology. 2019. 157:2. 173;184. DOI: 10.1111/imm.13063
Mc Ardle R., Del Din S., Galna B., Thomas A., Rochester L. Differentiating dementia disease subtypes with gait analysis: feasibility of wearable sensors? Gait and Posture. 2020. DOI: 10.1016/j.gaitpost.2019.12.028
Mc Ardle R., Galna B., Donaghy P., Thomas A., Rochester L. Do Alzheimer’s and Lewy body disease have discrete pathological signatures of gait? Alzheimer’s and Dementia. 2019. DOI: 10.1016/j.jalz.2019.06.4953
McMackin R., Muthuraman M., Groppa S., Babiloni C., Taylor J.-P. Measuring network disruption in neurodegenerative diseases: New approaches using signal analysis. Journal of Neurology, Neurosurgery and Psychiatry. 2019. DOI: 10.1136/jnnp-2018-319581
McErlane F., Armitt G., Cobb J., Bailey K., Cleary G., et al. incl. Foster H. CAPTURE-JIA: A consensus-derived core dataset to improve clinical care for children and young people with juvenile idiopathic arthritis. Rheumatology (United Kingdom). 2020. DOI: 10.1093/rheumatology/kez214
McMeekin N., Chrysos A.E., Vale L., Fisher A.J. Incorporating ex-vivo lung perfusion into the UK adult lung transplant service: an economic evaluation and decision analytic model. BMC health services research. Vol: 19:1. 2019. DOI: 10.1186/s12913-019-4154-6
Mehraram R., Kaiser M., Cromarty R., Graziadio S., O’Brien J.T., et al. incl. Taylor J.-P. Weighted network measures reveal differences between dementia types: An EEG study. Human Brain Mapping. 2019. DOI: 10.1002/hbm.24896
Meinke P., Kerr A.R.W., Czapiewski R., de las Heras J.I., Dixon C.R., et al. incl. Straub V. A multistage sequencing strategy pinpoints novel candidate alleles for Emery-Dreifuss muscular dystrophy and supports gene misregulation as its pathomechanism. EBioMedicine. 2020. DOI: 10.1016/j.ebiom.2019.11.048
Mendonça N., Kingston A., Granic A., Hill T.R., et al inc. Mathers J.C. Contribution of protein intake and its interaction with physical activity to transitions between disability states and to death in very old adults: the Newcastle 85+ Study. European Journal of Nutrition. 2019. DOI: 10.1007/s00394-019-02041-1
Migliavacca E., Tay S.K.H., Patel H.P., Sonntag T., Civiletto G., et al. incl. Sayer A.A. Mitochondrial oxidative capacity and NAD+ biosynthesis are reduced in human sarcopenia across ethnicities. Nature Communications. 2019. DOI: 10.1038/s41467-019-13694-1
Miyamoto S.T., Lendrem D.W., Ng W.-F., Hackett K.L., Valim V. Managing fatigue in patients with primary sjögren’s syndrome: Challenges and solutions. Open Access Rheumatology: Research and Reviews. 11. 77-88. 2019. DOI: 10.2147/OARRR.S167990
Mohamed M.O., Kinnaird T., Anderson R., Rashid M et al. inc. Zaman A.G., Combinations of bleeding and ischemic risk and their association with clinical outcomes in acute coronary syndrome. International Journal of Cardiology. 2019. DOI: 10.1016/j.ijcard.2019.05.035
Moloney E., Watson H., Barge D., Allen A.J., Carey P., et al. incl. Simpson A.J. Efficiency and Health Economic Evaluations of BD OneFlow™ Flow Cytometry Reagents for Diagnosing Chronic Lymphoid Leukemia. Cytometry Part B – Clinical Cytometry. 2019. DOI: 10.1002/cyto.b.21779
Moore H.L., Kelly T. et.al. incl. McFarland R, Turnbull D. Gorman G, Cognitive deficits in adult m.3243A>G- and m.8344A>G-related mitochondrial disease: importance of correcting for baseline intellectual ability. Annals of Clinical and Translational Neurology. 2019. DOI: 10.1002/acn3.736
Muir K.W., Bulters D., Willmot M., Sprigg N., Dixit A., et al. Intracerebral implantation of human neural stem cells and motor recovery after stroke: Multicentre prospective single-arm study (PISCES-2). Journal of Neurology, Neurosurgery and Psychiatry. 2020. DOI: 10.1136/jnnp-2019-322515
Moore H.L., Blain A.P., Turnbull D.M., Gorman G.S. Systematic review of cognitive deficits in adult mitochondrial disease. European Journal of Neurology. 2020. DOI: 10.1111/ene.14068
Neal M.A., Pippard B.J., Hollingsworth K.G., Maunder A., Dutta P., et al. incl. Simpson A.J. Optimized and accelerated 19F-MRI of inhaled perfluoropropane to assess regional pulmonary ventilation. Magnetic Resonance in Medicine. 2019. DOI: 10.1002/mrm.27805
Nicolson P., Perry R., Fisher A., Scott G., et al inc., Biss T., A HaemSTAR-led, UK-wide ‘flash-mob’ audit of -intravenous immunoglobulin use in immune –thrombocytopenia. Clinical medicine (London, England). 2019. 19. 82-83. DOI: 10.7861/clinmedicine.19-3-s82
Noli L., Khorsandi S.E., Pyle A., Giritharan G., Fogarty N., et al. incl. Chinnery P.F. Effects of thyroid hormone on mitochondria and metabolism of human preimplantation embryos. Stem Cells. 2019. DOI: 10.1002/stem.3129
Oakley F., Gee L.M., Sheerin N.S., Borthwick L.A. Implementation of pre-clinical methodologies to study fibrosis and test anti-fibrotic therapy. Current Opinion in Pharmacology. 2019. DOI: 10.1016/j.coph.2019.10.004
Odeniyi A.O., Embleton N., Ngongalah L., Akor W., Rankin J. Breastfeeding beliefs and experiences of African immigrant mothers in high-income countries: A systematic review. Maternal and Child Nutrition. 2020. DOI: 10.1111/mcn.12970
O’Connell R.L., Rattay T., Dave R.V., Trickey A., Skillman J. et al. incl. Collis N. on behalf of the iBRA-2 Steering Group, the Breast Reconstruction Research Collaborative. The impact of immediate breast reconstruction on the time to delivery of adjuvant therapy: the iBRA-2 study. British Journal of Cancer. DOI: 10.1038/s41416-019-0438-1
O’Dowd S., Schumacher J., Burn D.J., Bonanni L., Onofrj M, et al. incl. Thomas, A and Taylor J.-P. Fluctuating cognition in the Lewy body dementias. Brain : a journal of neurology. 2019. DOI: 10.1093/brain/awz235
Okwose N.C., Avery L., O’Brien N., Cassidy S., Charman S.J., et al. incl. MacGowan G.A. and Jakovljevic D.G. Acceptability, Feasibility and Preliminary Evaluation of a Novel, Personalised, Home-Based Physical Activity Intervention for Chronic Heart Failure (Active-at-Home-HF): a Pilot Study. Sports Medicine – Open. 2019. DOI: 10.1186/s40798-019-0216-x
Oláhová M., Berti C.C., Collier J.J., Alston C.L., et al. inlc. Horvath R and Chinnery, P.F. Molecular genetic investigations identify new clinical phenotypes associated with BCS1L-related mitochondrial disease. Human molecular genetics. 2019. DOI: 10.1093/hmg/ddz202
Oldroyd A.G.S., Lilleker J.B., Williams J., Chinoy H., Miller J.A.L. Long-term strength and functional status in inclusion body myositis and identification of trajectory subgroups. Muscle and Nerve. 2020. DOI: 10.1002/mus.26859
Paish H.L., Baldock T.E., Gillespie C.S., del Carpio Pons A., Mann D.A., et al. icl. Borthwick L.A. Chronic, Active Inflammation in Patients With Failed Total Knee Replacements Undergoing Revision Surgery. Journal of Orthopaedic Research. 2019. DOI: 10.1002/jor.24398
Paish H.L., Baldock T.E., Gillespie C.S., del Carpio Pons A., Mann D.A. Chronic, Active Inflammation in Patients With Failed Total Knee Replacements Undergoing Revision Surgery. Journal of Orthopaedic Research. 2019. DOI: 10.1002/jor.24398
Paish H.L., Reed L.H., Brown H., Bryan M.C., Govaere O., et al. incl. Borthwick L.A. A Bioreactor Technology for Modeling Fibrosis in Human and Rodent Precision-Cut Liver Slices. Hepatology. 2019. DOI: 10.1002/hep.30651
Paish H.L., Reed L.H., Brown H., Bryan M.C., Govaere O., et al. incl. Griffiths C. A Bioreactor Technology for Modeling Fibrosis in Human and Rodent Precision-Cut Liver Slices. Hepatology. 2019. DOI: 10.1002/hep.30651
Paish H.L., Reed L.H., Brown H., Bryan M.C., Govaere O., et al. incl. White S.A. A Bioreactor Technology for Modeling Fibrosis in Human and Rodent Precision-Cut Liver Slices. Hepatology. 2019. DOI: 10.1002/hep.30651
Paish H.L., Reed L.H., Brown H., Bryan M.C., Govaere O., et al. incl. Mann D.A. A Bioreactor Technology for Modeling Fibrosis in Human and Rodent Precision-Cut Liver Slices. Hepatology. 2019. DOI: 10.1002/hep.30651
Pan S., Tsakok T., Dand N., Lonsdale D.O., Loeff F.C., et al. incl. Reynolds N.J. Using Real-World Data to Guide Ustekinumab Dosing Strategies for Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study. Clinical and Translational Science. 2020. DOI: 10.1111/cts.12725
Parr J.R., Brice S., Welsh P., Ingham B., Le Couteur A., et al. Treating anxiety in autistic adults: Study protocol for the Personalised Anxiety Treatment-Autism (PAT-A©) pilot randomised controlled feasibility trial. Trials. 2020. DOI: 10.1186/s13063-020-4161-2
Pedrosa M., Seyedkazemi S., Francque S., Sanyal A., Rinella M., et al. incl. Anstee Q.M. A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial. Contemporary Clinical Trials. 2020. DOI: 10.1016/j.cct.2019.105889
Peraza L.R., Díaz-Parra A., Kennion O., Moratal D., Taylor J.-P. Structural connectivity centrality changes mark the path toward Alzheimer’s disease. Alzheimer’s and Dementia: Diagnosis, Assessment and Disease Monitoring. 2019. DOI: 10.1016/j.dadm.2018.12.004
Persson Ö., Muthukumar Y., Basu S., Jenninger L., Uhler J.P., et al. incl. McFarland R. Copy-choice recombination during mitochondrial L-strand synthesis causes DNA deletions. Nature Communications. 2019. DOI: 10.1038/s41467-019-08673-5
Persson Ö., Muthukumar Y., Basu S., Jenninger L., Uhler J.P. et al. incl. McFarland R. Copy-choice recombination during mitochondrial L-strand synthesis causes DNA deletions. Nature Communications. 2019; 10:1 759 DOI: 10.1038/s41467-019-08673-5
Petrova N.L., Donaldson N.K., Tang W., MacDonald A., Allen J., et al. incl. Leech N. Infrared thermography and ulcer prevention in the high-risk diabetic foot: data from a single-blind multicentre controlled clinical trial. Diabetic Medicine. 2020. DOI: 10.1111/dme.14152
Popescu D.-M., Botting R.A., Stephenson E., Green K., Webb S., et al. incl. Reynolds G. Decoding human fetal liver haematopoiesis. Nature. 2019. DOI: 10.1038/s41586-019-1652-y
Potts A.J., Cano C., Thomas S.H.L., Hill S.L. Synthetic cannabinoid receptor agonists: classification and nomenclature. Clinical Toxicology. 2020. DOI: 10.1080/15563650.2019.1661425
Pozarickij A., Williams C., Hysi P.G., Guggenheim J.A., Aslam T., et al. incl. Steel D. Quantile regression analysis reveals widespread evidence for gene-environment or gene-gene interactions in myopia development. Communications Biology. 2019. DOI: 10.1038/s42003-019-0387-5
Preshaw P.M., Bissett S.M. Periodontitis and diabetes. British Dental Journal. 2019. DOI: 10.1038/s41415-019-0794-5
Rehman R.Z.U., Del Din S., Guan Y., Yarnall A.J., Shi J.Q., Rochester L. Selecting Clinically Relevant Gait Characteristics for Classification of Early Parkinson’s Disease: A Comprehensive Machine Learning Approach. Scientific Reports. 2019. DOI: 10.1038/s41598-019-53656-7
Ridgley L.A., Anderson A.E., Maney N.J., Naamane N., et al inc. Pratt A.G. L-6 mediated transcriptional programming of naïve CD4+ T cells in early rheumatoid arthritis drives dysregulated effector function. Frontiers in Immunology. 2019. DOI: 10.3389/fimmu.2019.01535
Robinson S., Granic A., Sayer A.A. Nutrition and muscle strength, as the key component of sarcopenia: An overview of current evidence. Nutrients. 2019. DOI: 10.3390/nu11122942
Romagnoni A., Jégou S., Van Steen K., Wainrib G., Hugot J.-P., et al. incl. Walker M. Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data. Scientific Reports. 2019. DOI: 10.1038/s41598-019-46649-z
Romagnoni A., Jégou S., Van Steen K., Wainrib G., Hugot J.-P., et al. incl. Mansfield J. Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data. Scientific Reports. 2019. DOI: 10.1038/s41598-019-46649-z
Romagnoni A., Jégou S., Van Steen K., Wainrib G., et al inc. Walker M., Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data. Scientific Reports. 9:1. 2019. DOI: 10.1038/s41598-019-46649-z
Rowlands G., Tabassum B., Campbell P., Harvey S., Vaittinen A., et al. The evidence‐based development of an intervention to improve clinical health literacy practice. International Journal of Environmental Research and Public Health. 2020. DOI: 10.3390/ijerph17051513
Russell A., Gaunt D., Cooper K., Horwood J., Barton S., et al. incl. Parr J. Guided self-help for depression in autistic adults: The ADEPT feasibility RCT. Health Technology Assessment. 2019. DOI: 10.3310/hta23680
Saoura M., Powell C.A., Kopajtich R., Alahmad A., AL-Balool H.H., et al. incl. McFarland R. Mutations in ELAC2 associated with hypertrophic cardiomyopathy impair mitochondrial tRNA 3′-end processing. Human Mutation. 2019. DOI: 10.1002/humu.23777
Saoura M., Powell C.A., Kopajtich R., Alahmad A., AL-Balool H.H., et al. incl. Horvath R. Mutations in ELAC2 associated with hypertrophic cardiomyopathy impair mitochondrial tRNA 3′-end processing. Human Mutation. 2019. DOI: 10.1002/humu.23777
Sazonovs A., Kennedy N.A., Moutsianas L., Heap G.A., Rice D.L., et al. incl. Mansfield J. HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease. Gastroenterology. 2020. DOI: 10.1053/j.gastro.2019.09.041
Schumacher J., Cromarty R., Gallagher P., Firbank M.J., Thomas A.J., et al. inc. Taylor J.-P. Structural correlates of attention dysfunction in Lewy body dementia and Alzheimer’s disease: an ex-Gaussian analysis. Journal of Neurology. 2019. DOI: 10.1007/s00415-019-09323-y
Schumacher J., Peraza L.R., Firbank M., Thomas A.J. et al inc. Taylor J.-P. Dysfunctional brain dynamics and their origin in Lewy body dementia. Brain : a journal of neurology. 142:6. 1767-1782. 2019. DOI: 10.1093/brain/awz069
Schumacher J., Thomas A.J., Taylor J.-P. Dynamic functional connectivity changes in Lewy body disease. Brain : a journal of neurology. 2019. DOI: 10.1093/brain/awz315
Sevinc M., Stamp S., Ling J., Carter N., et al inc. Sheerin N.S. Comparison of the Outcome of Kidney Transplant After Pulsatile or Continuous Ex Vivo Hypothermic Machine Perfusion of Kidneys Donated After Cardiac Death: Analysis of Kidney Pairs. Transplantation proceedings. 51:6. 1785-1790. 2019. DOI: 10.1016/j.transproceed.2019.03.025
Signorelli M., Ayoglu B., Johansson C., Lochmüller H., Straub V., Muntoni F. Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy. Journal of Cachexia, Sarcopenia and Muscle. 2019. DOI: 10.1002/jcsm.12517
Sleeman I., Lawson R.A., Duncan G.W et al inc. Burn D and Yarnall A.J. Urate and Homocysteine: Predicting Motor and Cognitive Changes in Newly Diagnosed Parkinson’s Disease. Journal of Parkinson’s Disease. Volume 9:2. Pages 351-359. 2019. DOI: 10.3233/JPD-181535
Speight J., Holmes-Truscott E., Little S.A., Leelarathna L., Walkinshaw E. Satisfaction with the use of different technologies for insulin delivery and glucose monitoring among adults with long-standing type 1 diabetes and problematic hypoglycemia: 2-Year follow-up in the HypoCOMPaSS randomized clinical trial. Diabetes Technology and Therapeutics. 2019. DOI: 10.1089/dia.2019.0152
Spiering R., Jansen M.A.A., Wood M.J., Fath A.A., Eltherington O., et al. incl. Pratt A.G. Targeting of tolerogenic dendritic cells to heat-shock proteins in inflammatory arthritis. Journal of Translational Medicine. 2019. DOI: 10.1186/s12967-019-2128-4
Spiliopoulou A., Colombo M., Plant D., Nair N., Cui J. et al. incl. Isaacs J.D. Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for CD40 and CD39. Annals of the Rheumatic Diseases 1:1 2019. DOI: 10.1136/annrheumdis-2018-214877
Stapleton C.P., Heinzel A., Guan W., van der Most P.J., van Setten J, et al. incl. Sheerin N. The impact of donor and recipient common clinical and genetic variation on estimated glomerular filtration rate in a European renal transplant population. American Journal of Transplantation. 2019. DOI: 10.1111/ajt.15326
Steele H., Gomez-Duran A., Pyle A., Hopton S., Newman J., et al. incl. Chinnery P.F. and Horvath R. Metabolic effects of bezafibrate in mitochondrial disease. EMBO Molecular Medicine. 2020. DOI: 10.15252/emmm.201911589
Stuart S., Lawson R.A., Yarnall A.J.., Rochester L., et al inc. Burn D.J., Pro-Saccades Predict Cognitive Decline in Parkinson’s Disease: ICICLE-PD. Movement Disorders. 2019. DOI: 10.1002/mds.27813
Stuart S., Lawson R.A., Yarnall A.J., Nell J. et al inc. Alcock L and Rochester, L. Pro-Saccades Predict Cognitive Decline in Parkinson’s Disease: ICICLE-PD. Movement Disorders. 2019. DOI: 10.1002/mds.27813
Taylor L.J., Charman T., Howlin P., Slonims V., Green J., et al. incl. Parr J.R. Brief Report: Associations Between Preverbal Social Communication Skills, Language and Symptom Severity in Children with Autism: An Investigation Using the Early Sociocognitive Battery. Journal of Autism and Developmental Disorders. 2020. DOI: 10.1007/s10803-020-04364-z
Taylor J.J., Jaedicke K.M., van de Merwe R.C., Bissett S.M., Landsdowne N. et al. incl. Preshaw P.M. A Prototype Antibody-based Biosensor for Measurement of Salivary MMP-8 in Periodontitis using Surface Acoustic Wave Technology. Scientific Reports. 2019. DOI: 10.1038/s41598-019-47513-w
Taylor J.-P., McKeith I.G., Burn D.J., Boeve B.F., Weintraub D. New evidence on the management of Lewy body dementia. The Lancet Neurology. 2020. DOI: 10.1016/S1474-4422(19)30153-X
Taylor L., Parsons J., Taylor D., Binns E., Lord S., et al. incl. Rochester L. Evaluating the effects of an exercise program (Staying UpRight) for older adults in long-term care on rates of falls: Study protocol for a randomised controlled trial. Trials. 2020. DOI: 10.1186/s13063-019-3949-4
Terziroli Beretta-Piccoli B., Mieli-Vergani G., Vergani D., Vierling J.M., Adams D., et al. incl. Jones D. The challenges of primary biliary cholangitis: What is new and what needs to be done. Journal of Autoimmunity. 2019. DOI: 10.1016/j.jaut.2019.102328
Traianos E.Y., Locke J., Lendrem D., Bowman S., Hargreaves B., et al. incl. Ng W.-F. Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren’s syndrome. Rheumatology International. 2020. DOI: 10.1007/s00296-020-04524-5
Tsakok T., Wilson N., Dand N., Loeff F.C., Bloem K., et al. incl. Reynolds N.J. Association of Serum Ustekinumab Levels with Clinical Response in Psoriasis. JAMA Dermatology. 2019. DOI: 10.1001/jamadermatol.2019.1783
Ur Rehman R.Z., Del Din S., Shi J.Q., Galna B., Lord S., Yarnall A.J., Guan Y., Rochester L. Comparison of walking protocols and gait assessment systems for machine learning-based classification of parkinson’s disease. Sensors (Switzerland). 2019. DOI: 10.3390/s19245363
Vallance A.E., Harji D., Fearnhead N.S., Acheson A., Adams K. et al. inc. Griffiths B., Making an IMPACT: A priority setting consultation exercise to improve outcomes in patients with locally advanced, recurrent and metastatic colorectal cancer. European Journal of Surgical Oncology. 2019. DOI: 10.1016/j.ejso.2019.04.005
Vallance A.E., Harji D., Fearnhead N.S., Acheson A., Adams K., et al. incl. Griffiths B. Making an IMPACT: A priority setting consultation exercise to improve outcomes in patients with locally advanced, recurrent and metastatic colorectal cancer. European Journal of Surgical Oncology. 2019. DOI: 10.1016/j.ejso.2019.04.005
Van der Lee S.J., Conway O.J., Jansen I., Carrasquillo M. et al inc. Chinnery P.F. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity. Acta Neuropathologica. 2019. DOI: 10.1007/s00401-019-02026-8
Van Eimeren T., Antonini A., Berg D., Bohnen N., Ceravolo R., et al. incl. Pavese N. Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System. Alzheimer’s and Dementia: Diagnosis, Assessment and Disease Monitoring. 2019. DOI: 10.1016/j.dadm.2019.01.011
Venter M., Tomas C., Pienaar I.S., Strassheim V., Erasmus E., et al. incl. Newton J.L. MtDNA population variation in Myalgic encephalomyelitis/Chronic fatigue syndrome in two populations: a study of mildly deleterious variants. Scientific Reports. 2019. DOI: 10.1038/s41598-019-39060-1
Walker L., Stefanis L., Attems J. Clinical and neuropathological differences between Parkinson’s disease, Parkinson’s disease dementia and dementia with Lewy bodies – current issues and future directions. Journal of Neurochemistry. 2019. 68:1 DOI: 10.1111/jnc.14698
Wallace A., Pietrusz A., Dewar E., Dudziec M., Jones K. et al. incl. Trenell M. Community exercise is feasible for neuromuscular diseases and can improve aerobic capacity. Neurology. 2019; 92:15 e1773-e1785. DOI: 10.1212/WNL.0000000000007265
Wei W., Tuna S., Keogh M.J., Smith K.R., et al inc., Chinnery P.F. Germline selection shapes human mitochondrial DNA diversity. Science (New York, N.Y.). 364:6442. 2019. DOI: 10.1126/science.aau6520
Wilman H.R., Parisinos C.A., Atabaki-Pasdar N., Kelly M. et al inc. Walker M., Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration. Journal of Hepatology. 2019. DOI: 10.1016/j.jhep.2019.05.032
Witham M.D., Price R.J.G., Band M.M., Hannah M.S., Fulton R.L. Effect of Vitamin K2 on Postural Sway in Older People Who Fall: A Randomized Controlled Trial. Journal of the American Geriatrics Society. 2019. DOI: 10.1111/jgs.16024
Yiu Z.Z.N., Mason K.J., Barker J.N.W.N., Hampton P.J. A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real-world populations in psoriasis. British Journal of Dermatology. 2019. DOI: 10.1111/bjd.17849
Younossi Z.M., Ratziu V., Loomba R., Rinella M., Anstee Q.M., Goodman Z. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. The Lancet. 2019. DOI: 10.1016/S0140-6736(19)33041
Younossi Z.M., Stepanova M., Anstee Q.M., Lawitz E.J., Wai-Sun Wong V et al. Reduced Patient-Reported Outcome Scores Associate With Level of Fibrosis in Patients With Nonalcoholic Steatohepatitis. Clinical Gastroenterology and Hepatology. 2019. DOI: 10.1016/j.cgh.2019.02.024
Zhu G., Catt M., Cassidy S., Birch-Machin M., Trenell M., Hiden H. Objective sleep assessment in >80,000 UK mid-life adults: Associations with sociodemographic characteristics, physical activity and caffeine. PLoS ONE. 2019. DOI: 10.1371/journal.pone.0226220